Identification of risk for neonatal haemolysis
- PMID: 29532503
- DOI: 10.1111/apa.14316
Identification of risk for neonatal haemolysis
Abstract
Aim: To identify neonates at risk of haemolytic hyperbilirubinaemia through near-concurrent measurements of total serum/plasma bilirubin (TB) or transcutaneous bilirubin (TcB) and end-tidal breath carbon monoxide (CO), corrected for ambient CO (ETCOc), an index of bilirubin production and haemolysis.
Methods: Paired TB/TcB (mg/dL) and ETCOc (ppm) measurements were obtained in newborns (n = 283) at 20 to <60 hours of age in five nurseries. TB/TcB values were assigned TB/TcB percentile risk values using the Bhutani hour-specific nomogram. In infants having two serial TB/TcB measurements (n = 76), TB rate of rise (ROR, mg/dL/h) was calculated.
Results: For the entire cohort (n = 283), 67.1% and 32.9% had TB/TcB<75th and ≥75th percentile, respectively. TB/TcB (5.79 ± 1.84 vs 9.14 ± 2.25 mg/dL) and ETCOc (1.61 ± 0.45 vs 2.02 ± 1.35 ppm, p = 0.0002) were different between the groups. About 36.6% of infants with TB/TcB ≥75th percentile had ETCOc ≥ 2.0 ppm. In the subcohort of infants with serial TB/TcB measurements (n = 76), 44.7% and 55.3% had TB/TcB<75th and ≥75th percentile, respectively. TB/TcB (5.28 ± 1.97 vs 9.53 ± 2.78 mg/dL), ETCOc (1.72 ± 0.48 vs 2.38 ± 1.89 ppm, p = 0.05) and TB ROR (0.011 ± 0.440 vs 0.172 ± 0.471 mg/dL/h) were different between the groups.
Conclusion: The combined use of TB/TcB percentile risk assessments and ETCOc measurements can identify infants with haemolytic hyperbilirubinaemia. The addition of TB ROR can identify those infants with elimination disorders.
Keywords: Bilirubin production; Carbon monoxide; Haemolysis; Haemolytic hyperbilirubinaemia; Newborn jaundice.
©2018 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.
Similar articles
-
An End-Tidal Carbon Monoxide Nomogram for Term and Late-Preterm Chinese Newborns.J Pediatr. 2022 Nov;250:16-21.e3. doi: 10.1016/j.jpeds.2022.07.003. Epub 2022 Jul 11. J Pediatr. 2022. PMID: 35835229
-
Identification of neonatal haemolysis: an approach to predischarge management of neonatal hyperbilirubinemia.Acta Paediatr. 2016 May;105(5):e189-94. doi: 10.1111/apa.13341. Epub 2016 Feb 29. Acta Paediatr. 2016. PMID: 26802319 Clinical Trial.
-
Validation of transcutaneous bilirubin nomogram in identifying neonates not at risk of hyperbilirubinaemia: a prospective, observational, multicenter study.Early Hum Dev. 2012 Jan;88(1):51-5. doi: 10.1016/j.earlhumdev.2011.07.001. Epub 2011 Jul 23. Early Hum Dev. 2012. PMID: 21782360
-
End-tidal carbon monoxide and hemolysis.J Perinatol. 2014 Aug;34(8):577-81. doi: 10.1038/jp.2014.66. Epub 2014 Apr 17. J Perinatol. 2014. PMID: 24743136 Review.
-
Neonatal hyperbilirubinemia management: Clinical assessment of bilirubin production.Semin Perinatol. 2021 Feb;45(1):151351. doi: 10.1016/j.semperi.2020.151351. Epub 2020 Dec 1. Semin Perinatol. 2021. PMID: 33308896 Review.
Cited by
-
Severe Presentation of Congenital Hemolytic Anemias in the Neonatal Age: Diagnostic and Therapeutic Issues.Diagnostics (Basel). 2021 Aug 26;11(9):1549. doi: 10.3390/diagnostics11091549. Diagnostics (Basel). 2021. PMID: 34573891 Free PMC article. Review.
-
Erythrokinetic mechanism(s) causing the "late anemia" of hemolytic disease of the fetus and newborn.J Perinatol. 2024 Jun;44(6):916-919. doi: 10.1038/s41372-024-01872-z. Epub 2024 Jan 12. J Perinatol. 2024. PMID: 38216678 Review.
-
Breath Biomarkers in Diagnostic Applications.Molecules. 2021 Sep 11;26(18):5514. doi: 10.3390/molecules26185514. Molecules. 2021. PMID: 34576985 Free PMC article. Review.
-
End-tidal carbon monoxide for routine monitoring of significant hemolysis in the management of newborn hyperbilirubinemia.J Perinatol. 2025 Jul;45(7):957-960. doi: 10.1038/s41372-025-02242-z. Epub 2025 Feb 26. J Perinatol. 2025. PMID: 40011553 Free PMC article.
-
Is it time for a precision health approach to the management of newborn hyperbilirubinemia?J Perinatol. 2024 Jun;44(6):920-923. doi: 10.1038/s41372-024-01941-3. Epub 2024 Mar 21. J Perinatol. 2024. PMID: 38514741 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical